Clinicopathological Characteristics and Factors Affecting Recurrence of Ductal Carcinoma In Situ in Korean Women

被引:1
作者
Kim, Ji Sun [1 ]
Moon, Hyeong-Gon [1 ]
Ahn, Soo Kyung [1 ]
Min, Jun Won [2 ]
Shin, Hee Chul [1 ]
Kim, Han Suk [1 ]
Yeom, Cha Kyung [1 ]
Ha, Sung Hwan [3 ]
Chie, Eui Kyu [3 ]
Han, Wonshik [1 ,4 ]
Noh, Dong Young [1 ,4 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
[2] Dankook Univ, Coll Med, Dept Surg, Cheonan, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
关键词
Age; Breast neoplasms; Ductal carcinoma in situ; Radiotherapy; Recurrence; BREAST-CONSERVING SURGERY; MARGIN STATUS; LOCAL RECURRENCE; SENTINEL NODE; CANCER; CONSERVATION; RADIATION; OUTCOMES; THERAPY; DCIS;
D O I
10.4048/jbc.2010.13.4.392
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: As breast cancer screening becomes more popular in Korea, incidence of ductal carcinoma in situ (DCIS) of breast has increased to more than 10% of all breast cancer diagnosed. We aimed to show the clinicopathological characteristics and factors affecting recurrence of DCIS in Korean women. Methods: We retrospectively reviewed 152 DCIS patients who underwent breast conserving surgery in Seoul National University Hospital between January 1995 and December 2005. Results: Mean age at diagnosis was 46.7 years (24 to 66 years). Mean follow up duration of the patients was 73.82 months (0.80 to 168.43 months). Recurrence of disease occurred in 19 (12.5%) patients: 2 in contralateral breast, 15 in ipsilateral breast, and 2 in axilla. One patient showed ipsilateral breast recur after excision of axillary metastasis. Eight (42.11%) of all recurrence was infiltrating ductal carcinoma and one of them showed bone metastasis during follow up. In an multivariate analysis of factors affecting recurrence, younger age at diagnosis and omission of radiotherapy had significant association with recurrence (p=0.005 and p=0.002, respectively). However, tumor size (p=0.862), microinvasion (p=0.988), histologic grade (p=0.157), estrogen receptor status (p=0.401) and resection margin status (p=0.112) were not significantly correlated with recurrence. There was no breast cancer associated mortality. Conclusion: In this study, we found that the younger age at diagnosis and omission of adjuvant radiotherapy are independent predictors of recurrence in Korean DCIS patients.
引用
收藏
页码:392 / 397
页数:6
相关论文
共 29 条
[1]   National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009 [J].
Allegra, Carmen J. ;
Aberle, Denise R. ;
Ganschow, Pamela ;
Hahn, Stephen M. ;
Lee, Clara N. ;
Millon-Underwood, Sandra ;
Pike, Malcolm C. ;
Reed, Susan D. ;
Saftlas, Audrey F. ;
Scarvalone, Susan A. ;
Schwartz, Arnold M. ;
Slomski, Carol ;
Yothers, Greg ;
Zon, Robin .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (03) :161-169
[2]   Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution [J].
Allred, D. Craig ;
Wu, Yun ;
Mao, Sufeng ;
Nagtegaal, Iris D. ;
Lee, Sangjun ;
Perou, Charles M. ;
Mohsin, Syed K. ;
O'Connell, Peter ;
Tsimelzon, Anna ;
Medina, Dan .
CLINICAL CANCER RESEARCH, 2008, 14 (02) :370-378
[3]   Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. [J].
Bartelink, H ;
Horiot, J ;
Poortmans, P ;
Struikmans, H ;
Van den Bogaert, W ;
Barillot, I ;
Fourquet, A ;
Borger, J ;
Jager, J ;
Hoogenraad, W ;
Collette, L ;
Pierart, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) :1378-1387
[4]   Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853 [J].
Bijker, N ;
Peterse, JL ;
Duchateau, L ;
Julien, JP ;
Fentiman, IS ;
Duval, C ;
Di Palma, S ;
Simony-Lafontaine, J ;
de Mascarel, I ;
van de Vijver, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2263-2271
[5]   Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery [J].
Boland, GP ;
Chan, KC ;
Knox, WF ;
Roberts, SA ;
Bundred, NJ .
BRITISH JOURNAL OF SURGERY, 2003, 90 (04) :426-432
[6]   Cyclooxygenase-2 Inhibition Does Not Improve the Reduction in Ductal Carcinoma In situ Proliferation with Aromatase Inhibitor Therapy: Results of the ERISAC Randomized Placebo-Controlled Trial [J].
Bundred, Nigel J. ;
Cramer, Angela ;
Morris, Julie ;
Renshaw, Lorna ;
Cheung, Kwok-Leung ;
Flint, Pamela ;
Johnson, Rachael ;
Young, Oliver ;
Landberg, Goeran ;
Grassby, Sue ;
Turner, Lorraine ;
Baildam, Andrew ;
Barr, Lester ;
Dixon, Michael .
CLINICAL CANCER RESEARCH, 2010, 16 (05) :1605-1612
[7]   The Role of Preoperative Magnetic Resonance Imaging for Detecting the Extent of Disease and Predicting the Prognosis of Ductal Carcinoma In Situ [J].
Chung, Yoo Seung ;
Lee, Youn Soo ;
Jeh, Su-Kyung ;
Song, Byung-Joo ;
Kim, Jeong Soo ;
Jeon, Hae Myung ;
Jeong, Sang-Seol ;
Park, Woo-Chan .
JOURNAL OF BREAST CANCER, 2009, 12 (02) :106-112
[8]   Relationship Between Clinical and Pathologic Features of Ductal Carcinoma In Situ and Patient Age An Analysis of 657 Patients [J].
Collins, Laura C. ;
Achacoso, Ninah ;
Nekhlyudov, Larissa ;
Fletcher, Suzanne W. ;
Haque, Reina ;
Quesenberry, Charles P., Jr. ;
Puligandla, Balaram ;
Alshak, Najeeb S. ;
Goldstein, Lynn C. ;
Gown, Allen M. ;
Schnitt, Stuart J. ;
Habel, Laurel A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (12) :1802-1808
[9]   Effect of Margin Status on Local Recurrence After Breast Conservation and Radiation Therapy for Ductal Carcinoma In Situ [J].
Dunne, Clive ;
Burke, John P. ;
Morrow, Monica ;
Kell, Malcolm R. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) :1615-1620
[10]  
Frykberg ER, 1997, BREAST J, V3, P227